I tried calling shire and they are clueless, the last told me to go to trial.gov. it lists a former employee of V Pharma, she is still listed on the trial. Gov page. I contacted her and she said she no longer works for shire. I definitely think it's a go on by shire but the delay is confusing, but I still believe they are trying to work out a deal.
It appears Shire's had interest in Friedreich's Ataxia for awhile now.
Jun 15, 2012 - Shire Human Genetic Therapies, Inc.
The present invention provides, among other things, compositions and methods for treatment of Friedrich's Ataxia based on effective targeting of a therapeutic moiety to mitochondria that can substitute for natural FXN protein activity or rescue one or more phenotypes or symptoms associated with frataxin-deficiency. In some embodiments, the present invention provides a targeted therapeutic comprising a therapeutic moiety, which is a polypeptide having an N-terminus and a C-terminus, a mitochondrial targeting sequence associated with the therapeutic moiety at the N-terminus, and a mitochondrial membrane-penetrating peptide associated with the therapeutic moiety at the C-terminus, wherein the therapeutic moiety is targeted to mitochondria upon cellular entry.
Patent History Patent number: 9260495 Type: Grant Filed: Jun 15, 2012 Date of Patent: Feb 16, 2016 Patent Publication Number: 20140135275 Assignee: Shire Human Genetic Therapies, Inc. (Lexington, MA) Inventors: Dennis Keefe (Wilmington, MA), Michael Concino (Bolton, MA), Michael Heartlein (Boxborough, MA), Serene Josiah (Cambridge, MA), Bettina Strack-Logue (Somerville, MA) Primary Examiner: Alexander Kim Application Number: 14/127,074
patents.justia.com/patent/9260495
I believe most of the inventors are still with Shire.